A species of gram-negative bacteria causing URINARY TRACT INFECTIONS and SEPTICEMIA.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.
Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.
Infections with bacteria of the genus KLEBSIELLA.
Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.
A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock.
4-carbon straight chain aliphatic hydrocarbons substituted with two hydroxyl groups. The hydroxyl groups cannot be on the same carbon atom.
Infections with bacteria of the family ENTEROBACTERIACEAE.
An enzyme that catalyzes the dehydration of 1,2-propanediol to propionaldehyde. EC 4.2.1.28.
Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in humans and other animals including MAMMALS; BIRDS; REPTILES; and AMPHIBIANS. It has also been isolated from SOIL and WATER as well as from clinical specimens such as URINE; THROAT; SPUTUM; BLOOD; and wound swabs as an opportunistic pathogen.
Monocyclic, bacterially produced or semisynthetic beta-lactam antibiotics. They lack the double ring construction of the traditional beta-lactam antibiotics and can be easily synthesized.
Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
Proteins found in any species of bacterium.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in water, sewage, soil, meat, hospital environments, and on the skin and in the intestinal tract of man and animals as a commensal.
A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The functional hereditary units of BACTERIA.
A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
Deoxyribonucleic acid that makes up the genetic material of bacteria.
A parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate EUKARYOTA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.
Cobamides are a class of compounds that function as cofactors in various enzymatic reactions, containing a corrin ring similar to vitamin B12, but with different substituents on the benzimidazole moiety, and can be found in certain bacteria and archaea.
Substances that reduce the growth or reproduction of BACTERIA.
A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes vascular wilts on a wide range of plant species. It was formerly named Erwinia chrysanthemi.
Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA.
Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
Retrograde flow of urine from the URINARY BLADDER into the URETER. This is often due to incompetence of the vesicoureteral valve leading to ascending bacterial infection into the KIDNEY.
A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.
An abnormal elevation of body temperature, usually as a result of a pathologic process.
A chronic inflammatory condition of the KIDNEY resulting in diffuse renal destruction, a grossly enlarged and nonfunctioning kidney associated with NEPHROLITHIASIS and KIDNEY STONES.
Radiography of any part of the urinary tract.
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.
Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID.
Hydrocarbon-rich byproducts from the non-fossilized BIOMASS that are combusted to generate energy as opposed to fossilized hydrocarbon deposits (FOSSIL FUELS).
The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.
Postmortem examination of the body.
Refers to the whole process of grieving and mourning and is associated with a deep sense of loss and sadness.
Physicians appointed to investigate all cases of sudden or violent death.
The application of pathology to questions of law.
Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.
The terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.

AcrAB Efflux System: Expression and Contribution to Fluoroquinolone Resistance in Klebsiella spp. (1/92)

Seven Klebsiella pneumoniae and four Klebsiella oxytoca clinical isolates with different levels of resistance to ciprofloxacin were studied. Mutations in the topoisomerase genes were found in almost all strains, but the contribution of a multidrug efflux system homologous to AcrAB in Escherichia coli was also observed. Overexpression of this efflux system was demonstrated by immunoblotting with antibodies against E. coli AcrA.  (+info)

Ammonium hydroxide hydrolysis: a valuable support in the MALDI-TOF mass spectrometry analysis of Lipid A fatty acid distribution. (2/92)

Lipid A is the lipophilic moiety of lipopolysaccharides (LPSs), the major components of the external membrane of almost all gram-negative bacteria. It is responsible for the toxicity of LPS and has a heterogeneous structure composed of a bis-phosphorylated glucosamine disaccharide backbone that is acylated at the positions 2, 3 of the GlcN I (proximal) and GlcN II (distal) residue with O- and N-linked 3-hydroxy fatty acids (primary substitution). These fatty acids are further acylated by means of their 3-hydroxy groups (secondary substitution). The toxicity of Lipid A is dependent on its primary structure; the number, the length, and the distribution of the fatty acids on the disaccharide backbone strongly influence the endotoxic activity. In this paper a general and easy methodology to obtain secondary fatty acid distribution, which is one of the most difficult issues in the structural determination of Lipid A, is proposed. The method combines ammonium hydroxide hydrolysis and matrix assisted laser desorption ionization (MALDI)-mass spectrometry analysis and has been successfully proven with five different Lipid A species. The procedure exploits the lower stability under mild alkaline conditions of acyl and acyloxyacyl esters with respect to that of the acyl and acyloxyacyl amides. The partially degraded Lipid A species obtained are analyzed by MALDI-MS. The generality of this approach was tested on five Lipid As, namely those arising from Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas reactans, and Burkholderia caryophylli.  (+info)

Identification of the essential histidine residue for high-affinity binding of AlbA protein to albicidin antibiotics. (3/92)

The albA gene from Klebsiella oxytoca encodes a protein that binds albicidin phytotoxins and antibiotics with high affinity. Previously, it has been shown that shifting pH from 6 to 4 reduces binding activity of AlbA by about 30%, indicating that histidine residues might be involved in substrate binding. In this study, molecular analysis of the albA coding region revealed sequence discrepancies with the albA sequence reported previously, which were probably due to sequencing errors. The albA gene was subsequently cloned from K. oxytoca ATCC 13182(T) to establish the revised sequence. Biochemical and molecular approaches were used to determine the functional role of four histidine residues (His(78), His(125), His(141) and His(189)) in the corrected sequence for AlbA. Treatment of AlbA with diethyl pyrocarbonate (DEPC), a histidine-specific alkylating reagent, reduced binding activity by about 95 %. DEPC treatment increased absorbance at 240-244 nm by an amount indicating conversion to N-carbethoxyhistidine of a single histidine residue per AlbA molecule. Pretreatment with albicidin protected AlbA against modification by DEPC, with a 1 : 1 molar ratio of albicidin to the protected histidine residues. Based on protein secondary structure and amino acid surface probability indices, it is predicted that His(125) might be the residue required for albicidin binding. Mutation of His(125) to either alanine or leucine resulted in about 32 % loss of binding activity, and deletion of His(125) totally abolished binding activity. Mutation of His(125) to arginine and tyrosine had no effect. These results indicate that His(125) plays a key role either in an electrostatic interaction between AlbA and albicidin or in the conformational dynamics of the albicidin-binding site.  (+info)

Enterobacterial repetitive intergenic consensus 1R PCR assay for detection of Raoultella sp. isolates among strains identified as Klebsiella oxytoca in the clinical laboratory. (4/92)

The enterobacterial repetitive intergenic consensus 1R PCR method, which provided recognizable profiles for reference strains of the three species of Raoultella and the two genetic groups of Klebsiella oxytoca, was applied to 19 clinical isolates identified as K. oxytoca. By this method, as confirmed by species-specific gene sequencing, two Raoultella ornithinolytica and two unclassifiable K. oxytoca isolates were identified.  (+info)

Structural rationalization for the lack of stereospecificity in coenzyme B12-dependent diol dehydratase. (5/92)

Adenosylcobalamin-dependent diol dehydratase of Klebsiella oxytoca is apparently not stereospecific and catalyzes the conversion of both (R)- and (S)-1,2-propanediol to propionaldehyde. To explain this unusual property of the enzyme, we analyzed the crystal structures of diol dehydratase in complexes with cyanocobalamin and (R)- or (S)-1,2-propanediol. (R)- and (S)-isomers are bound in a symmetrical manner, although the hydrogen-bonding interactions between the substrate and the active-site residues are the same. From the position of the adenosyl radical in the modeled "distal" conformation, it is reasonable for the radical to abstract the pro-R and pro-S hydrogens from (R)- and (S)-isomers, respectively. The hydroxyl groups in the substrate radicals would migrates from C(2) to C(1) by a suprafacial shift, resulting in the stereochemical inversion at C(1). This causes 60 degrees clockwise and 70 degrees counterclockwise rotations of the C(1)-C(2) bond of the (R)- and (S)-isomers, respectively, if viewed from K+. A modeling study of 1,1-gem-diol intermediates indicated that new radical center C(2) becomes close to the methyl group of 5'-deoxyadenosine. Thus, the hydrogen back-abstraction (recombination) from 5'-deoxyadenosine by the product radical is structurally feasible. It was also predictable that the substitution of the migrating hydroxyl group by a hydrogen atom from 5'-deoxyadenosine takes place with the inversion of the configuration at C(2) of the substrate. Stereospecific dehydration of the 1,1-gem-diol intermediates can also be rationalized by assuming that Asp-alpha335 and Glu-alpha170 function as base catalysts in the dehydration of the (R)- and (S)-isomers, respectively. The structure-based mechanism and stereochemical courses of the reaction are proposed.  (+info)

Recognition of two genetic groups in the Klebsiella oxytoca taxon on the basis of chromosomal beta-lactamase and housekeeping gene sequences as well as ERIC-1 R PCR typing. (6/92)

Whilst searching for a molecular method to identify the different species of Raoultella and Klebsiella oxytoca, it was observed that the OXY-1 and OXY-2 beta-lactamase-producing K. oxytoca isolates displayed two distinguishable enterobacterial repetitive intergenic consensus (ERIC)-1R profiles. It was hypothesized that the two groups of chromosomal beta-lactamases might correspond to two groups of strains in the K. oxytoca taxon. To confirm this hypothesis, clinical isolates and reference strains of K. oxytoca were studied by determination of the sequence of their bla(OXY) genes, and of a partial fragment of their 16S rRNA (387 bp) and rpoB (512 bp) genes. The sequence data were phylogenetically analysed by using the parsimony method. Four clinical isolates possessed a bla(OXY-1) gene and nine possessed a bla(OXY-2) gene. The mean percentage of rpoB and 16S rRNA gene identity was > 99% within each group of strains, whereas it was 96.56 +/- 0.24% for rpoB genes and 97.80 +/- 0.22% for 16S rRNA genes between the group of strains harbouring the bla(OXY-1) gene and the group harbouring the bla(OXY-2) gene. The phylogenetic tree resulting from combined analysis of the 16S rRNA and rpoB datasets showed that the K. oxytoca isolates were monophyletic and separated into two clades; these clades included strains with either the bla(OXY-1) gene or the bla(OXY-2) gene. This result was supported with high bootstrap values of 97 and 99%, respectively. Moreover, the two groups of strains displayed distinct ERIC-1R profiles, with bands characteristic of each profile. Thus, the chromosomal bla(OXY) gene sequence is able to delineate not only two groups of beta-lactamases in K. oxytoca, but also two clades in the K. oxytoca taxon, in a manner similar to the sequence of housekeeping genes. These results suggest that K. oxytoca should be divided into two genetic groups, group OXY-1 represented by K. oxytoca strain SL781 (=CIP 104963) and group OXY-2 by K. oxytoca strain SL91l (= CIP 106098).  (+info)

New Klebsiella oxytoca beta-lactamase genes bla(OXY-3) and bla(OXY-4) and a third genetic group of K oxytoca based on bla(OXY-3). (7/92)

The two genetic groups (oxy-1 and oxy-2) previously identified in the Klebsiella oxytoca taxon are recognizable by four independent molecular markers: (i). ERIC-1R profiles, (ii). 16S ribosomal DNA (rDNA) signature sequences, (iii). singular nucleotides in a defined fragment of the rpoB gene, and (iv) the type of the strain's bla(OXY) gene (i.e., bla(OXY-1) or bla(OXY-2)). K. oxytoca strains SG266 and SG271 could not be classified into these genetic groups based on their ERIC-1R profile and bla(OXY) gene sequence. With regard to the gene identity percentages between the bla(OXY-1) and bla(OXY-2) gene groups (86.8% +/- 0.4%) and within a bla(OXY) gene group (>99%), it was concluded that the bla(OXY) gene of strain SG271 was representative of a new bla(OXY) gene group (bla(OXY-3)), since the mean identity percentages between it and the two bla(OXY) gene groups were 85.5% +/- 0.2% and 84.4% +/- 0.4%, respectively. Since the corresponding percentages were 95.0% +/- 0.4% and 86.2% +/- 0.3% for strain SG266, it was impossible to classify its bla(OXY) gene, which was therefore named bla(OXY-4). The 16S rDNA signature sequences of the two strains could be determined only after cloning experiments. The SG266 clones displayed the same signature sequence as that of the genetic group oxy-1, whereas the SG271 clones displayed three different 16S rDNA signature sequences that also differed from those of the two genetic groups. Singular nucleotides were found within the rpoB sequence of the two strains, allowing for their distinction from the two genetic groups. All of these results, combined with those previously obtained by the ERIC-1R PCR method, indicate that strain SG271 is representative of a new K. oxytoca genetic group (oxy-3), whereas strain SG266 could not be classified.  (+info)

Ligation mediated PCR performed at low denaturation temperatures--PCR melting profiles. (8/92)

We show that using low denaturation temperatures (80-88 degrees C) during ligation mediated PCR (LM PCR) of bacterial DNA leads to the amplification of limited sets of the less stable DNA fragments. A set of electrophoretic patterns of such fragments obtained at different denaturation temperatures forms the PCR melting profile (PCR MP). A single pattern obtained for a given temperature and a set of patterns arising after application of several denaturation temperatures (PCR MP) are very specific for the given bacterial genome and may be used for strain characterisation and differentiation. The method may also be used for amplification and isolation of the less stable DNA fragments in a genome.  (+info)

"Klebsiella oxytoca" is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that is part of the family Enterobacteriaceae. It is a normal inhabitant of the human gastrointestinal tract and can be found in soil, water, and plants. In clinical settings, K. oxytoca can cause various types of infections, including pneumonia, bloodstream infections, wound infections, and urinary tract infections. It is known to produce a variety of beta-lactamases, enzymes that can hydrolyze and inactivate certain antibiotics, making it resistant to some forms of treatment. Its identification is important for appropriate antimicrobial therapy and infection control measures.

Klebsiella is a genus of Gram-negative, facultatively anaerobic, encapsulated, non-motile, rod-shaped bacteria that are part of the family Enterobacteriaceae. They are commonly found in the normal microbiota of the mouth, skin, and intestines, but can also cause various types of infections, particularly in individuals with weakened immune systems.

Klebsiella pneumoniae is the most common species and can cause pneumonia, urinary tract infections, bloodstream infections, and wound infections. Other Klebsiella species, such as K. oxytoca, can also cause similar types of infections. These bacteria are resistant to many antibiotics, making them difficult to treat and a significant public health concern.

"Klebsiella pneumoniae" is a medical term that refers to a type of bacteria belonging to the family Enterobacteriaceae. It's a gram-negative, encapsulated, non-motile, rod-shaped bacterium that can be found in various environments, including soil, water, and the gastrointestinal tracts of humans and animals.

"Klebsiella pneumoniae" is an opportunistic pathogen that can cause a range of infections, particularly in individuals with weakened immune systems or underlying medical conditions. It's a common cause of healthcare-associated infections, such as pneumonia, urinary tract infections, bloodstream infections, and wound infections.

The bacterium is known for its ability to produce a polysaccharide capsule that makes it resistant to phagocytosis by white blood cells, allowing it to evade the host's immune system. Additionally, "Klebsiella pneumoniae" has developed resistance to many antibiotics, making infections caused by this bacterium difficult to treat and a growing public health concern.

Klebsiella infections are caused by bacteria called Klebsiella spp., with the most common species being Klebsiella pneumoniae. These gram-negative, encapsulated bacilli are normal inhabitants of the human gastrointestinal tract and upper respiratory tract but can cause various types of infections when they spread to other body sites.

Commonly, Klebsiella infections include:

1. Pneumonia: This is a lung infection that can lead to symptoms like cough, chest pain, difficulty breathing, and fever. It often affects people with weakened immune systems, chronic lung diseases, or those who are hospitalized.

2. Urinary tract infections (UTIs): Klebsiella can cause UTIs, particularly in individuals with compromised urinary tracts, such as catheterized patients or those with structural abnormalities. Symptoms may include pain, burning during urination, frequent urges to urinate, and lower abdominal or back pain.

3. Bloodstream infections (bacteremia/septicemia): When Klebsiella enters the bloodstream, it can cause bacteremia or septicemia, which can lead to sepsis, a life-threatening condition characterized by an overwhelming immune response to infection. Symptoms may include fever, chills, rapid heart rate, and rapid breathing.

4. Wound infections: Klebsiella can infect wounds, particularly in patients with open surgical wounds or traumatic injuries. Infected wounds may display redness, swelling, pain, pus discharge, and warmth.

5. Soft tissue infections: These include infections of the skin and underlying soft tissues, such as cellulitis and abscesses. Symptoms can range from localized redness, swelling, and pain to systemic symptoms like fever and malaise.

Klebsiella infections are increasingly becoming difficult to treat due to their resistance to multiple antibiotics, including carbapenems, which has led to the term "carbapenem-resistant Enterobacteriaceae" (CRE) or "carbapenem-resistant Klebsiella pneumoniae" (CRKP). These infections often require the use of last-resort antibiotics like colistin and tigecycline. Infection prevention measures, such as contact precautions, hand hygiene, and environmental cleaning, are crucial to controlling the spread of Klebsiella in healthcare settings.

Beta-lactamases are enzymes produced by certain bacteria that can break down and inactivate beta-lactam antibiotics, such as penicillins, cephalosporins, and carbapenems. This enzymatic activity makes the bacteria resistant to these antibiotics, limiting their effectiveness in treating infections caused by these organisms.

Beta-lactamases work by hydrolyzing the beta-lactam ring, a structural component of these antibiotics that is essential for their antimicrobial activity. By breaking down this ring, the enzyme renders the antibiotic ineffective against the bacterium, allowing it to continue growing and potentially causing harm.

There are different classes of beta-lactamases (e.g., Ambler Class A, B, C, and D), each with distinct characteristics and mechanisms for breaking down various beta-lactam antibiotics. The emergence and spread of bacteria producing these enzymes have contributed to the growing problem of antibiotic resistance, making it increasingly challenging to treat infections caused by these organisms.

To overcome this issue, researchers have developed beta-lactamase inhibitors, which are drugs that can bind to and inhibit the activity of these enzymes, thus restoring the effectiveness of certain beta-lactam antibiotics. Examples of such combinations include amoxicillin/clavulanate (Augmentin) and piperacillin/tazobactam (Zosyn).

Enterobacteriaceae is a family of gram-negative, rod-shaped bacteria that are commonly found in the intestines of humans and animals. Many species within this family are capable of causing various types of infections, particularly in individuals with weakened immune systems. Some common examples of Enterobacteriaceae include Escherichia coli (E. coli), Klebsiella pneumoniae, Proteus mirabilis, and Salmonella enterica.

These bacteria are typically characterized by their ability to ferment various sugars and produce acid and gas as byproducts. They can also be distinguished by their biochemical reactions, such as their ability to produce certain enzymes or resist specific antibiotics. Infections caused by Enterobacteriaceae can range from mild to severe, depending on the species involved and the overall health of the infected individual.

Some infections caused by Enterobacteriaceae include urinary tract infections, pneumonia, bloodstream infections, and foodborne illnesses. Proper hygiene, such as handwashing and safe food handling practices, can help prevent the spread of these bacteria and reduce the risk of infection.

Butylene glycols are a type of organic compounds that belong to the class of diols, which are chemical compounds containing two hydroxyl groups. Specifically, butylene glycols are composed of a four-carbon chain with two hydroxyl groups located on adjacent carbon atoms.

There are two isomeric forms of butylene glycol: 1,2-butanediol and 1,3-butanediol.

* 1,2-Butanediol (also known as 1,2-butylene glycol) has the hydroxyl groups on the first and second carbon atoms of the chain. It is a colorless, viscous liquid that is used as a solvent, humectant, and antifreeze in various industrial and cosmetic applications.
* 1,3-Butanediol (also known as 1,3-butylene glycol) has the hydroxyl groups on the first and third carbon atoms of the chain. It is also a colorless, viscous liquid that is used as a solvent, humectant, and antifreeze in various industrial and cosmetic applications.

Butylene glycols are generally considered to be safe for use in cosmetics and other consumer products, although they may cause skin irritation or allergic reactions in some individuals. They are also used as intermediates in the synthesis of other chemicals, such as polyesters and polyurethanes.

Enterobacteriaceae are a large family of gram-negative bacteria that are commonly found in the human gut and surrounding environment. Infections caused by Enterobacteriaceae can occur when these bacteria enter parts of the body where they are not normally present, such as the bloodstream, urinary tract, or abdominal cavity.

Enterobacteriaceae infections can cause a range of symptoms depending on the site of infection. For example:

* Urinary tract infections (UTIs) caused by Enterobacteriaceae may cause symptoms such as frequent urination, pain or burning during urination, and lower abdominal pain.
* Bloodstream infections (bacteremia) caused by Enterobacteriaceae can cause fever, chills, and sepsis, a potentially life-threatening condition characterized by a whole-body inflammatory response to infection.
* Pneumonia caused by Enterobacteriaceae may cause cough, chest pain, and difficulty breathing.
* Intra-abdominal infections (such as appendicitis or diverticulitis) caused by Enterobacteriaceae can cause abdominal pain, fever, and changes in bowel habits.

Enterobacteriaceae infections are typically treated with antibiotics, but the increasing prevalence of antibiotic-resistant strains of these bacteria has made treatment more challenging in recent years. Preventing the spread of Enterobacteriaceae in healthcare settings and promoting good hygiene practices can help reduce the risk of infection.

Propanediol Dehydratase is not a medical term per se, but rather a biochemical term. It refers to an enzyme that catalyzes the conversion of 1,2-propanediol (also known as propylene glycol) into propionaldehyde and water in the metabolic pathway known as the glycerol/propanediol utilization (GUD) system.

The reaction catalyzed by Propanediol Dehydratase is:
(CH3)2CH(OH)CH2OH → CH3CH2CHO + H2O

This enzyme is found in certain bacteria and archaea that are capable of utilizing 1,2-propanediol as a carbon source for growth. Deficiency or absence of this enzyme can affect the metabolic capabilities of these microorganisms.

Beta-lactam resistance is a type of antibiotic resistance in which bacteria have developed the ability to inactivate or circumvent the action of beta-lactam antibiotics. Beta-lactams are a class of antibiotics that include penicillins, cephalosporins, carbapenems, and monobactams. They work by binding to and inhibiting the activity of enzymes called penicillin-binding proteins (PBPs), which are essential for bacterial cell wall synthesis.

Bacteria can develop beta-lactam resistance through several mechanisms:

1. Production of beta-lactamases: These are enzymes that bacteria produce to break down and inactivate beta-lactam antibiotics. Some bacteria have acquired genes that encode for beta-lactamases that can hydrolyze and destroy the beta-lactam ring, rendering the antibiotic ineffective.
2. Alteration of PBPs: Bacteria can also develop mutations in their PBPs that make them less susceptible to beta-lactams. These alterations can reduce the affinity of PBPs for beta-lactams or change their conformation, preventing the antibiotic from binding effectively.
3. Efflux pumps: Bacteria can also develop efflux pumps that actively pump beta-lactam antibiotics out of the cell, reducing their intracellular concentration and limiting their effectiveness.
4. Biofilm formation: Some bacteria can form biofilms, which are communities of microorganisms that adhere to surfaces and are encased in a protective matrix. Biofilms can make bacteria more resistant to beta-lactams by preventing the antibiotics from reaching their targets.

Beta-lactam resistance is a significant public health concern because it limits the effectiveness of these important antibiotics. The overuse and misuse of beta-lactams have contributed to the emergence and spread of resistant bacteria, making it essential to use these antibiotics judiciously and develop new strategies to combat bacterial resistance.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

'Citrobacter freundii' is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that is commonly found in the environment, including water, soil, and plants. It is also part of the normal gut flora in humans and animals. The bacterium can cause various types of infections in people with weakened immune systems, such as newborns, the elderly, and those with chronic diseases. Infections caused by 'Citrobacter freundii' may include urinary tract infections, pneumonia, bloodstream infections, and wound infections. Proper identification and antibiotic susceptibility testing are crucial for effective treatment of these infections.

Monobactams are a type of antibiotics that contain a single bacterial cell wall-binding component, known as a monocyclic beta-lactam. Aztreonam is an example of a monobactam that is used clinically to treat various infections caused by Gram-negative bacteria, including some strains of Pseudomonas aeruginosa. Monobactams work by inhibiting the enzyme responsible for building the bacterial cell wall, leading to bacterial death. They are not affected by beta-lactamases, which are enzymes produced by some bacteria that can inactivate other types of beta-lactam antibiotics, such as penicillins and cephalosporins.

Beta-lactams are a class of antibiotics that include penicillins, cephalosporins, carbapenems, and monobactams. They contain a beta-lactam ring in their chemical structure, which is responsible for their antibacterial activity. The beta-lactam ring inhibits the bacterial enzymes necessary for cell wall synthesis, leading to bacterial death. Beta-lactams are commonly used to treat a wide range of bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and bone and joint infections. However, some bacteria have developed resistance to beta-lactams through the production of beta-lactamases, enzymes that can break down the beta-lactam ring and render the antibiotic ineffective. To overcome this resistance, beta-lactam antibiotics are often combined with beta-lactamase inhibitors, which protect the beta-lactam ring from degradation.

A plasmid is a small, circular, double-stranded DNA molecule that is separate from the chromosomal DNA of a bacterium or other organism. Plasmids are typically not essential for the survival of the organism, but they can confer beneficial traits such as antibiotic resistance or the ability to degrade certain types of pollutants.

Plasmids are capable of replicating independently of the chromosomal DNA and can be transferred between bacteria through a process called conjugation. They often contain genes that provide resistance to antibiotics, heavy metals, and other environmental stressors. Plasmids have also been engineered for use in molecular biology as cloning vectors, allowing scientists to replicate and manipulate specific DNA sequences.

Plasmids are important tools in genetic engineering and biotechnology because they can be easily manipulated and transferred between organisms. They have been used to produce vaccines, diagnostic tests, and genetically modified organisms (GMOs) for various applications, including agriculture, medicine, and industry.

Enterobacter is a genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, including in soil, water, and the gastrointestinal tracts of humans and animals. These bacteria are members of the family Enterobacteriaceae and are known to cause a variety of infections in humans, particularly in healthcare settings.

Enterobacter species are capable of causing a range of infections, including urinary tract infections, pneumonia, bacteremia, and wound infections. They are often resistant to multiple antibiotics, which can make treatment challenging. Infections with Enterobacter are typically treated with broad-spectrum antibiotics that are effective against gram-negative bacteria.

It's worth noting that while Enterobacter species can cause infections, they are also a normal part of the microbiota found in the human gut and usually do not cause harm in healthy individuals. However, if the bacterium enters the bloodstream or other sterile sites in the body, it can cause infection and illness.

Gram-negative bacteria are a type of bacteria that do not retain the crystal violet stain used in the Gram staining method, a standard technique used in microbiology to classify and identify different types of bacteria based on their structural differences. This method was developed by Hans Christian Gram in 1884.

The primary characteristic distinguishing Gram-negative bacteria from Gram-positive bacteria is the composition and structure of their cell walls:

1. Cell wall: Gram-negative bacteria have a thin peptidoglycan layer, making it more susceptible to damage and less rigid compared to Gram-positive bacteria.
2. Outer membrane: They possess an additional outer membrane that contains lipopolysaccharides (LPS), which are endotoxins that can trigger strong immune responses in humans and animals. The outer membrane also contains proteins, known as porins, which form channels for the passage of molecules into and out of the cell.
3. Periplasm: Between the inner and outer membranes lies a compartment called the periplasm, where various enzymes and other molecules are located.

Some examples of Gram-negative bacteria include Escherichia coli (E. coli), Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella enterica, Shigella spp., and Neisseria meningitidis. These bacteria are often associated with various infections, such as urinary tract infections, pneumonia, sepsis, and meningitis. Due to their complex cell wall structure, Gram-negative bacteria can be more resistant to certain antibiotics, making them a significant concern in healthcare settings.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

'Enterobacter cloacae' is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, including in soil, water, and the gastrointestinal tracts of humans and animals. They are part of the family Enterobacteriaceae and can cause various types of infections in humans, particularly in individuals with weakened immune systems or underlying medical conditions.

E. cloacae is known to be an opportunistic pathogen, which means that it typically does not cause disease in healthy people but can take advantage of a weakened host to cause infection. It can cause a range of infections, including urinary tract infections, pneumonia, bacteremia (bloodstream infections), and wound infections.

E. cloacae is often resistant to multiple antibiotics, which can make treatment challenging. In recent years, there has been an increase in the number of E. cloacae isolates that are resistant to carbapenems, a class of antibiotics that are typically reserved for treating serious infections caused by multidrug-resistant bacteria. This has led to concerns about the potential for untreatable infections caused by this organism.

Cephalosporins are a class of antibiotics that are derived from the fungus Acremonium, originally isolated from seawater and cow dung. They have a similar chemical structure to penicillin and share a common four-membered beta-lactam ring in their molecular structure.

Cephalosporins work by inhibiting the synthesis of bacterial cell walls, which ultimately leads to bacterial death. They are broad-spectrum antibiotics, meaning they are effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

There are several generations of cephalosporins, each with different spectra of activity and pharmacokinetic properties. The first generation cephalosporins have a narrow spectrum of activity and are primarily used to treat infections caused by susceptible Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae.

Second-generation cephalosporins have an expanded spectrum of activity that includes some Gram-negative organisms, such as Escherichia coli and Haemophilus influenzae. Third-generation cephalosporins have even broader spectra of activity and are effective against many resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Klebsiella pneumoniae.

Fourth-generation cephalosporins have activity against both Gram-positive and Gram-negative organisms, including some that are resistant to other antibiotics. They are often reserved for the treatment of serious infections caused by multidrug-resistant bacteria.

Cephalosporins are generally well tolerated, but like penicillin, they can cause allergic reactions in some individuals. Cross-reactivity between cephalosporins and penicillin is estimated to occur in 5-10% of patients with a history of penicillin allergy. Other potential adverse effects include gastrointestinal symptoms (such as nausea, vomiting, and diarrhea), neurotoxicity, and nephrotoxicity.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

A bacterial gene is a segment of DNA (or RNA in some viruses) that contains the genetic information necessary for the synthesis of a functional bacterial protein or RNA molecule. These genes are responsible for encoding various characteristics and functions of bacteria such as metabolism, reproduction, and resistance to antibiotics. They can be transmitted between bacteria through horizontal gene transfer mechanisms like conjugation, transformation, and transduction. Bacterial genes are often organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule.

It's important to note that the term "bacterial gene" is used to describe genetic elements found in bacteria, but not all genetic elements in bacteria are considered genes. For example, some DNA sequences may not encode functional products and are therefore not considered genes. Additionally, some bacterial genes may be plasmid-borne or phage-borne, rather than being located on the bacterial chromosome.

Aztreonam is a monobactam antibiotic, which is a type of antibacterial drug used to treat infections caused by bacteria. It works by interfering with the ability of bacterial cells to form cell walls, leading to their death. Aztreonam is specifically active against certain types of gram-negative bacteria, including Pseudomonas aeruginosa and Escherichia coli.

Aztreonam is available in various forms, including injectable solutions and inhaled powder, for use in different clinical settings. It is often used to treat serious infections that have not responded to other antibiotics or that are caused by bacteria that are resistant to other antibiotics.

Like all antibiotics, aztreonam can cause side effects, including nausea, vomiting, diarrhea, and headache. It may also cause allergic reactions in some people, particularly those with a history of allergies to other antibiotics. It is important to use aztreonam only as directed by a healthcare provider and to report any unusual symptoms or side effects promptly.

Bacterial DNA refers to the genetic material found in bacteria. It is composed of a double-stranded helix containing four nucleotide bases - adenine (A), thymine (T), guanine (G), and cytosine (C) - that are linked together by phosphodiester bonds. The sequence of these bases in the DNA molecule carries the genetic information necessary for the growth, development, and reproduction of bacteria.

Bacterial DNA is circular in most bacterial species, although some have linear chromosomes. In addition to the main chromosome, many bacteria also contain small circular pieces of DNA called plasmids that can carry additional genes and provide resistance to antibiotics or other environmental stressors.

Unlike eukaryotic cells, which have their DNA enclosed within a nucleus, bacterial DNA is present in the cytoplasm of the cell, where it is in direct contact with the cell's metabolic machinery. This allows for rapid gene expression and regulation in response to changing environmental conditions.

Genetic conjugation is a type of genetic transfer that occurs between bacterial cells. It involves the process of one bacterium (the donor) transferring a piece of its DNA to another bacterium (the recipient) through direct contact or via a bridge-like connection called a pilus. This transferred DNA may contain genes that provide the recipient cell with new traits, such as antibiotic resistance or virulence factors, which can make the bacteria more harmful or difficult to treat. Genetic conjugation is an important mechanism for the spread of antibiotic resistance and other traits among bacterial populations.

Cobamides are a class of compounds that are structurally related to vitamin B12 (cobalamin). They consist of a corrin ring, which is a large heterocyclic ring made up of four pyrrole rings, and a cobalt ion in the center. The lower axial ligand of the cobalt ion can be a variety of different groups, including cyano, hydroxo, methyl, or 5'-deoxyadenosyl groups.

Cobamides are involved in a number of important biological processes, including the synthesis of amino acids and nucleotides, the metabolism of fatty acids and cholesterol, and the regulation of gene expression. They function as cofactors for enzymes called cobamide-dependent methyltransferases, which transfer methyl groups (CH3) from one molecule to another.

Cobamides are found in a wide variety of organisms, including bacteria, archaea, and eukaryotes. In humans, the most important cobamide is vitamin B12, which is essential for the normal functioning of the nervous system and the production of red blood cells. Vitamin B12 deficiency can lead to neurological problems and anemia.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Carbapenems are a class of broad-spectrum beta-lactam antibiotics, which are used to treat severe infections caused by bacteria that are resistant to other antibiotics. They have a similar chemical structure to penicillins and cephalosporins but are more resistant to the enzymes produced by bacteria that can inactivate these other antibiotics. Carbapenems are often reserved for use in serious infections caused by multidrug-resistant organisms, and they are typically given intravenously in a hospital setting. Examples of carbapenems include imipenem, meropenem, doripenem, and ertapenem.

"Pectobacterium chrysanthemi" is a species of gram-negative, rod-shaped bacteria that belongs to the family Enterobacteriaceae. It is a plant pathogen that causes soft rot disease in a wide range of plants, including ornamental and vegetable crops. The bacterium produces pectolytic enzymes that break down pectin, a major component of plant cell walls, leading to maceration and rotting of the plant tissue. It is primarily transmitted through contaminated seeds, soil, and water, and can cause significant economic losses in agriculture. In humans, it is not considered a pathogen and does not cause disease.

Pyelonephritis is a type of urinary tract infection (UTI) that involves the renal pelvis and the kidney parenchyma. It's typically caused by bacterial invasion, often via the ascending route from the lower urinary tract. The most common causative agent is Escherichia coli (E. coli), but other bacteria such as Klebsiella, Proteus, and Pseudomonas can also be responsible.

Acute pyelonephritis can lead to symptoms like fever, chills, flank pain, nausea, vomiting, and frequent or painful urination. If left untreated, it can potentially cause permanent kidney damage, sepsis, or other complications. Chronic pyelonephritis, on the other hand, is usually associated with underlying structural or functional abnormalities of the urinary tract.

Diagnosis typically involves a combination of clinical evaluation, urinalysis, and imaging studies, while treatment often consists of antibiotics tailored to the identified pathogen and the patient's overall health status.

Urinary Tract Infections (UTIs) are defined as the presence of pathogenic microorganisms, typically bacteria, in any part of the urinary system, which includes the kidneys, ureters, bladder, and urethra, resulting in infection and inflammation. The majority of UTIs are caused by Escherichia coli (E. coli) bacteria, but other organisms such as Klebsiella, Proteus, Staphylococcus saprophyticus, and Enterococcus can also cause UTIs.

UTIs can be classified into two types based on the location of the infection:

1. Lower UTI or bladder infection (cystitis): This type of UTI affects the bladder and urethra. Symptoms may include a frequent and urgent need to urinate, pain or burning during urination, cloudy or strong-smelling urine, and discomfort in the lower abdomen or back.

2. Upper UTI or kidney infection (pyelonephritis): This type of UTI affects the kidneys and can be more severe than a bladder infection. Symptoms may include fever, chills, nausea, vomiting, and pain in the flanks or back.

UTIs are more common in women than men due to their shorter urethra, which makes it easier for bacteria to reach the bladder. Other risk factors for UTIs include sexual activity, use of diaphragms or spermicides, urinary catheterization, diabetes, and weakened immune systems.

UTIs are typically diagnosed through a urinalysis and urine culture to identify the causative organism and determine the appropriate antibiotic treatment. In some cases, imaging studies such as ultrasound or CT scan may be necessary to evaluate for any underlying abnormalities in the urinary tract.

Vesico-Ureteral Reflux (VUR) is a medical condition that affects the urinary system, specifically the junction where the ureters (tubes that carry urine from the kidneys to the bladder) connect with the bladder. In normal physiology, once the bladder fills up with urine and contracts during micturition (urination), the pressure within the bladder should prevent the backflow of urine into the ureters.

However, in VUR, the valve-like mechanism that prevents this backflow does not function properly, allowing urine to flow backward from the bladder into the ureters and potentially even into the kidneys. This reflux can lead to recurrent urinary tract infections (UTIs), kidney damage, and other complications if left untreated. VUR is more commonly diagnosed in children but can also occur in adults.

Technetium Tc 99m Dimercaptosuccinic Acid (DMSA) is a radiopharmaceutical agent used in nuclear medicine imaging procedures. The compound is made up of the radioisotope Technetium-99m, which emits gamma rays that can be detected by a gamma camera, and dimercaptosuccinic acid, which binds to certain types of metal ions in the body.

In medical imaging, Technetium Tc 99m DMSA is typically used to visualize the kidneys and detect any abnormalities such as inflammation, infection, or tumors. The compound is taken up by the renal tubules in the kidneys, allowing for detailed images of the kidney structure and function to be obtained.

It's important to note that the use of Technetium Tc 99m DMSA should be under the supervision of a trained medical professional, as with any radiopharmaceutical agent, due to the radiation exposure involved in its use.

Fever, also known as pyrexia or febrile response, is a common medical sign characterized by an elevation in core body temperature above the normal range of 36.5-37.5°C (97.7-99.5°F) due to a dysregulation of the body's thermoregulatory system. It is often a response to an infection, inflammation, or other underlying medical conditions, and it serves as a part of the immune system's effort to combat the invading pathogens or to repair damaged tissues.

Fevers can be classified based on their magnitude:

* Low-grade fever: 37.5-38°C (99.5-100.4°F)
* Moderate fever: 38-39°C (100.4-102.2°F)
* High-grade or severe fever: above 39°C (102.2°F)

It is important to note that a single elevated temperature reading does not necessarily indicate the presence of a fever, as body temperature can fluctuate throughout the day and can be influenced by various factors such as physical activity, environmental conditions, and the menstrual cycle in females. The diagnosis of fever typically requires the confirmation of an elevated core body temperature on at least two occasions or a consistently high temperature over a period of time.

While fevers are generally considered beneficial in fighting off infections and promoting recovery, extremely high temperatures or prolonged febrile states may necessitate medical intervention to prevent potential complications such as dehydration, seizures, or damage to vital organs.

Xanthogranulomatous pyelonephritis (XPN) is a rare and severe form of chronic pyelonephritis, which is an infection and inflammation of the renal pelvis. In XPN, there is a proliferation of lipid-laden macrophages (also known as xanthoma cells) and other inflammatory cells in the kidney parenchyma, leading to the formation of multiple granulomas.

XPN typically affects middle-aged to older women with underlying urologic abnormalities such as obstructive uropathy, calculi (stones), or chronic urinary tract infections. The condition can be difficult to diagnose and often requires a combination of imaging studies, urinalysis, and histopathological examination of renal tissue.

The clinical presentation of XPN is variable and may include fever, flank pain, weight loss, and symptoms related to urinary tract obstruction or infection. Treatment usually involves antibiotic therapy, surgical removal of the affected kidney (nephrectomy), and management of any underlying urologic abnormalities. If left untreated, XPN can lead to irreversible kidney damage and even sepsis.

Urography is a medical imaging technique used to examine the urinary system, which includes the kidneys, ureters, and bladder. It involves the use of a contrast material that is injected into a vein or given orally, which then travels through the bloodstream to the kidneys and gets excreted in the urine. This allows the radiologist to visualize the structures and any abnormalities such as tumors, stones, or blockages. There are different types of urography, including intravenous urography (IVU), CT urography, and retrograde urography.

Glycerol, also known as glycerine or glycerin, is a simple polyol (a sugar alcohol) with a sweet taste and a thick, syrupy consistency. It is a colorless, odorless, viscous liquid that is slightly soluble in water and freely miscible with ethanol and ether.

In the medical field, glycerol is often used as a medication or supplement. It can be used as a laxative to treat constipation, as a source of calories and energy for people who cannot eat by mouth, and as a way to prevent dehydration in people with certain medical conditions.

Glycerol is also used in the production of various medical products, such as medications, skin care products, and vaccines. It acts as a humectant, which means it helps to keep things moist, and it can also be used as a solvent or preservative.

In addition to its medical uses, glycerol is also widely used in the food industry as a sweetener, thickening agent, and moisture-retaining agent. It is generally recognized as safe (GRAS) by the U.S. Food and Drug Administration (FDA).

Fermentation is a metabolic process in which an organism converts carbohydrates into alcohol or organic acids using enzymes. In the absence of oxygen, certain bacteria, yeasts, and fungi convert sugars into carbon dioxide, hydrogen, and various end products, such as alcohol, lactic acid, or acetic acid. This process is commonly used in food production, such as in making bread, wine, and beer, as well as in industrial applications for the production of biofuels and chemicals.

Biofuels are defined as fuels derived from organic materials such as plants, algae, and animal waste. These fuels can be produced through various processes, including fermentation, esterification, and transesterification. The most common types of biofuels include biodiesel, ethanol, and biogas.

Biodiesel is a type of fuel that is produced from vegetable oils or animal fats through a process called transesterification. It can be used in diesel engines with little or no modification and can significantly reduce greenhouse gas emissions compared to traditional fossil fuels.

Ethanol is a type of alcohol that is produced through the fermentation of sugars found in crops such as corn, sugarcane, and switchgrass. It is typically blended with gasoline to create a fuel known as E85, which contains 85% ethanol and 15% gasoline.

Biogas is a type of fuel that is produced through the anaerobic digestion of organic materials such as food waste, sewage sludge, and agricultural waste. It is composed primarily of methane and carbon dioxide and can be used to generate electricity or heat.

Overall, biofuels offer a renewable and more sustainable alternative to traditional fossil fuels, helping to reduce greenhouse gas emissions and decrease dependence on non-renewable resources.

Sudden death is a term used to describe a situation where a person dies abruptly and unexpectedly, often within minutes to hours of the onset of symptoms. It is typically caused by cardiac or respiratory arrest, which can be brought on by various medical conditions such as heart disease, stroke, severe infections, drug overdose, or trauma. In some cases, the exact cause of sudden death may remain unknown even after a thorough post-mortem examination.

It is important to note that sudden death should not be confused with "sudden cardiac death," which specifically refers to deaths caused by the abrupt loss of heart function (cardiac arrest). Sudden cardiac death is often related to underlying heart conditions such as coronary artery disease, cardiomyopathy, or electrical abnormalities in the heart.

An autopsy, also known as a post-mortem examination or obduction, is a medical procedure in which a qualified professional (usually a pathologist) examines a deceased person's body to determine the cause and manner of death. This process may involve various investigative techniques, such as incisions to study internal organs, tissue sampling, microscopic examination, toxicology testing, and other laboratory analyses. The primary purpose of an autopsy is to gather objective evidence about the medical conditions and factors contributing to the individual's demise, which can be essential for legal, insurance, or public health purposes. Additionally, autopsies can provide valuable insights into disease processes and aid in advancing medical knowledge.

Bereavement is the state of loss or grief experienced when a person experiences the death of a loved one, friend, or family member. It is a normal response to the death of someone close and can involve a range of emotions such as sadness, anger, guilt, and anxiety. The grieving process can be different for everyone and can take time to work through. Professional support may be sought to help cope with the loss.

A coroner and medical examiner are officials in the legal system who are responsible for investigating and determining the cause of death in certain cases. While their roles can overlap, there are some differences between them.

A coroner is a public official who is typically appointed or elected to serve in a particular jurisdiction, such as a county or district. The coroner's primary responsibility is to investigate any sudden, unexpected, or suspicious deaths that occur within their jurisdiction. This may include deaths that occur due to violence, accidents, suicide, or unknown causes.

In order to determine the cause of death, the coroner may conduct an autopsy, order toxicology tests, and review medical records and other evidence. The coroner may also hold an inquest, which is a formal hearing in which witnesses are called to testify about the circumstances surrounding the death. Based on the evidence gathered during the investigation, the coroner will make a determination as to the cause and manner of death.

A medical examiner, on the other hand, is a physician who has completed specialized training in forensic pathology. Medical examiners are typically appointed or hired by a government agency, such as a state or county, to perform autopsies and investigate deaths.

Medical examiners are responsible for determining the cause of death in cases where there is a suspicion of foul play, as well as in other circumstances where the cause of death may not be immediately apparent. They may also testify in court as expert witnesses based on their findings.

In some jurisdictions, the roles of coroner and medical examiner are combined, with the official serving as both a public administrator and a trained physician. In other cases, the two roles are separate, with the coroner responsible for administrative functions and the medical examiner responsible for determining the cause of death.

Forensic pathology is a subspecialty of pathology that focuses on determining the cause and manner of death by examining a corpse. It involves applying scientific knowledge and techniques to investigate criminal or suspicious deaths, often in conjunction with law enforcement agencies. A forensic pathologist performs autopsies (postmortem examinations) to evaluate internal and external injuries, diseases, and other conditions that may have contributed to the individual's death. They also collect evidence such as tissue samples, which can be used for toxicological, microbiological, or histological analysis. The information gathered by forensic pathologists is crucial in helping to establish the facts surrounding a person's death and assisting legal proceedings.

The "cause of death" is a medical determination of the disease, injury, or event that directly results in a person's death. This information is typically documented on a death certificate and may be used for public health surveillance, research, and legal purposes. The cause of death is usually determined by a physician based on their clinical judgment and any available medical evidence, such as laboratory test results, autopsy findings, or eyewitness accounts. In some cases, the cause of death may be uncertain or unknown, and the death may be classified as "natural," "accidental," "homicide," or "suicide" based on the available information.

"Terminology as a topic" in the context of medical education and practice refers to the study and use of specialized language and terms within the field of medicine. This includes understanding the meaning, origins, and appropriate usage of medical terminology in order to effectively communicate among healthcare professionals and with patients. It may also involve studying the evolution and cultural significance of medical terminology. The importance of "terminology as a topic" lies in promoting clear and accurate communication, which is essential for providing safe and effective patient care.

Klebsiella+oxytoca at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Type strain of Klebsiella oxytoca ... "Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Klebsiella oxytoca in Austria". Antimicrobial Agents and ... Klebsiella oxytoca is a Gram-negative, rod-shaped bacterium that is closely related to K. pneumoniae, from which it is ... Klebsiella oxytoca has shown promise in industrial ethanol fuel production, and is referenced as being used to produce hydrogen ...
To download a certificate of origin for Klebsiella oxytoca (Flugge) Lautrop (49473), enter the lot number exactly as it appears ... To download a certificate of analysis for Klebsiella oxytoca (Flugge) Lautrop (49473), enter the lot number exactly as it ... The certificate of analysis for that lot of Klebsiella oxytoca (Flugge) Lautrop (49473) is not currently available online. ... The certificate of origin for that lot of Klebsiella oxytoca (Flugge) Lautrop (49473) is not currently available online. ...
Tag: Klebsiella oxytoca. Altered Antibiogram of Klebsiella oxytoca using The Trivedi Effect®. Klebsiella oxytoca is primarily a ... Klebsiella oxytoca, Mahendra Trivedi, Trivedi Effect, Trivedi Science1 Comment on Altered Antibiogram of Klebsiella oxytoca ... Klebsiella oxytoca (K. oxytoca) is a Gram-negative pathogen, cylindrical rod shaped, non-motile in nature, and belongs to ... Klebsiella spp. are ubiquitous in environment [1], but K. oxytoca can be cultured from intestines of healthy humans and animals ...
CCUG26509 - Klebsiella oxytoca, Deposit Date: 1990-04-11
Nosocomial extended-spectrum β-lactamase-producing Klebsiella oxytoca clinical isolates from patients in the intensive care ... Outbreak of Extended-Spectrum β-Lactamase-producing Klebsiella oxytoca Infections Associated with Contaminated Handwashing ... Outbreak of Extended-Spectrum β-Lactamase-producing Klebsiella oxytoca Infections Associated with Contaminated Handwashing ...
Hypersensitivity pneumonitis secondary to Klebsiella oxytoca. A new cause of humidifier lung.. G C Kane, J J Marx, D S Prince. ... hypersensitivity pneumonitis was confirmed by detection of serum-binding antibodies at significant titer to Klebsiella oxytoca ... This represents a newly recognized cause of hypersensitivity pneumonitis related to exposure to K oxytoca contaminating a ...
... ciprofloksacyny i tigecykliny wobec 52 szczepów pałeczek Klebsiella oxytoca. Najwyższy odsetek szczepów wrażliwych odnotowano ... na tigecyklinę - 84,6%. Abstract Fifty two clinical isolates of K. oxytoca were included ... Wrażliwość pałeczek Klebsiella oxytoca na wybrane antybiotyki. [Susceptibility of Klebsiella oxytoca to selected antibiotics]. ... ciprofloksacyny i tigecykliny wobec 52 szczepów pałeczek Klebsiella oxytoca. Najwyższy odsetek szczepów wrażliwych odnotowano ...
Klebsiella oxytoca protein. Ferrous iron transport peroxidase EfeB. A0A242MNR7_9BURK (A0A242MNR7). Caballeronia sordidicola ...
KLEBSIELLA OXYTOCA NPSA IN COMPLEX WITH 3-HYDROXYANTHRANILYL-AMSN - 6VHV , canSARS ...
Complicated Urinary Tract Infections caused by Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis, Proteus ... Klebsiella oxytoca Morganella morganii Proteus vulgaris Providencia rettgeri Providencia stuartii Serratia marcescens ...
Klebsiella oxytoca and species. * Proteus species. * Enterococcus faecalis and species. * Gram-positive organisms, including ...
Whole-genome sequence-informed MALDI-TOF MS diagnostics reveal importance of Klebsiella oxytoca group in invasive infections: a ... Whole-genome sequence-informed MALDI-TOF MS diagnostics reveal importance of Klebsiella oxytoca group in invasive infections: a ...
"АГРЕГАЦИЯ БАКТЕРИЙ KLEBSIELLA OXYTOCA И KLEBSIELLA PNEUMONIAE ПОД ВЛИЯНИЕМ ХИМИЧЕСКОГО ФАКТОРА ... THE AGGREGATION OF BACTERIA KLEBSIELLA OXYTOCA AND KLEBSIELLA PNEUMONIAE UNDER THE INFLUENCE OF CHEMICAL FACTOR ... Home , Archives , Vol 5, No 4 (2015) , THE AGGREGATION OF BACTERIA KLEBSIELLA OXYTOCA AND KLEBSIELLA PNEUMONIAE UNDER THE ... THE AGGREGATION OF BACTERIA KLEBSIELLA OXYTOCA AND KLEBSIELLA PNEUMONIAE UNDER THE INFLUENCE OF CHEMICAL FACTOR. ...
Here, we report a high production of 2,3-BDO from crude glycerol using the engineered Klebsiella oxytoca M3 in which pduC ( ... 2,3-BDO production from glycerol was dramatically enhanced by disruption of the pduC and ldhA genes in K. oxytoca M1 and 1,3- ... In fed-batch fermentation with the parent strain K. oxytoca M1, crude glycerol was more effective than pure glycerol as a ... oxytoca M3 vs. 189.5 g/L by K. oxytoca M1). The maximum DCW of K. oxytoca M3 was also greater than that of K. oxytoca M1 (8.6 g ...
OBJECTIVES: The objective of this study was to examine Klebsiella oxytoca clonal and phylogenetic diversity, based on an ... Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to ... METHODS: The study material comprised 68 rectal carriage K. oxytoca isolates non-susceptible to ESCs recovered in 2008-11 from ... CONCLUSIONS: The study confirmed the high genetic diversity of the collection of K. oxytoca ESC-non-susceptible isolates, ...
Moradigaravand D, Martin V, Peacock SJ, Parkhill J. Population structure of multidrug resistant Klebsiella oxytoca within ... Moradigaravand, D, Martin, V, Peacock, SJ & Parkhill, J 2017, Population structure of multidrug resistant Klebsiella oxytoca ... Population structure of multidrug resistant Klebsiella oxytoca within hospitals across the UK and Ireland identifies sharing of ... Population structure of multidrug resistant Klebsiella oxytoca within hospitals across the UK and Ireland identifies sharing of ...
Klebsiella oxytoca. Morganella morganii. Pantoea agglomerans. Proteus vulgaris. Providencia rettgeri. Providencia stuartii. ... Klebsiella pneumoniae Legionella pneumophila. Moraxella catarrhalis. Proteus mirabilis 1 MDRSP (Multi-drug resistant ... This regimen is indicated for cUTI due to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and AP due to E. coli, ... This regimen is indicated for cUTI due to Enterococcus faecalis, Enterococcus cloacae, Escherichia coli, Klebsiella pneumoniae ...
Klebsiella oxytoca + Pseudomonas oleovorans + Proteus vulgaris 1. Klebsiella oxytoca + Raoultella ornithinolytica + Alcaligenes ... Klebsiella oxytoca (7.8%), Klebsiella pneumoniae (4.3%), Citrobacter spp. (4.3%) and Proteus hauseri (4.3%) (Table 1). The ... Klebsiella oxytoca (7.8%), Klebsiella pneumoniae (4.3%), Citrobacter spp. (4.3%), Proteus hauseri (4.3%), Morganella morgannii ... Escherichia coli + Raoultella ornithinolytica + Klebsiella oxytoca 1. Escherichia coli + Raoultella ornithinolytica + ...
Klebsiella oxytoca Klebsiella pneumoniae Moraxella catarrhalis Morganella morganii Neisseria gonorrhoeae Neisseria meningitidis ... Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, Morganella morganii*, Pseudomonas aeruginosa, Serratia marcescens ... Caused by Escherichia coli, Klebsiella pneumoniae, Bacteroides fragilis, Clostridium species (Note: most strains of Clostridium ... Caused by Escherichia coli, Proteus mirabilis, Proteus vulgaris, Morganella morganii or Klebsiella pneumoniae. ...
Klebsiella oxytoca. 63. 100. R. 73. 97. 98. 98. 100. 77. 90. 98. 95. ... Klebsiella aerogenes (previously known as Enterobacter aerogenes). 49. 100. R. R. R. 90. 100. 100. R. 100. 100. ... Klebsiella oxytoca. 48. 100. R. 79. 92. 92. 98. 100. 92. 95. 96. ...
Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Proteus vulgaris Inherently resistant organisms Aerobic Gram- ...
Klebsiella oxytoca. *Klebsiella pneumoniae. *Pseudomonas aeruginosa. *Staphylococcus aureus. *Proteus spp.. *Pasteurella ...
Klebsiella oxytoca. Morganella morganii. Proteus vulgaris. Providencia rettgeri. Serratia marcescens. Stenotrophomonas ... Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex. ...
Acute necrotizing pyelonephritis due to Klebsiella oxytoca and Escherichia coli. The decedent was a 31-year-old woman with a ... community acquired organisms (eg, S pneumoniae, community-acquired methicillin-resistant S aureus [CA-MRSA] , Klebsiella ...
Resuscitation of ten-year VBNC Klebsiella oxytoca. Les Cahiers de Biologie Marine 49: 17-22. ...
Klebsiella oxytoca 0. 0. 2 (1.1). 2 (0.4). 0.13. Hafnia alvei 0. 0. 1 (0.5). 1 (0.2). 0.36. ... Klebsiella pneumoniae 13 (6.5). 14 (7.8). 16 (8.6). 43 (7.6). 0.73. Escherichia coli 4 (2.0). 4 (2.2). 3 (1.6). 11 (1.9). 0.92 ...
Klebsiella oxytoca: opportunistic infections in laboratory rodents. Lab Anim 42:369-375. doi:10.1258/la.2007.06026e. ...
One kind of bacteria called Klebsiella oxytoca reduces the amount of fungi that grow in manure. This bacteria competes with ...
Isethionate as a product from taurine during nitrogen-limited growth of Klebsiella oxytoca TauN1 ... including Klebsiella oxytoca TauN1 and Chromohalobacter salexigens DSM3043, and involves enzymes and transporters arranged in ... We recently reported the crystal structure of IsfD from K. oxytoca TauN1, in complex with NADPH and isethionate [8], and showed ... The previously reported IsfD-dependent pathways are largely found in Proteobacteria, including Klebsiella pneumoniae, a ...

No FAQ available that match "klebsiella oxytoca"

No images available that match "klebsiella oxytoca"